Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands.
Saved in:
| Title: | Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands. |
|---|---|
| Authors: | Probert F; Department of Chemistry, University of Oxford, Oxford, United Kingdom., Yeo T; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Department of Neurology, National Neuroscience Institute, Singapore, Singapore.; Duke-National University of Singapore (NUS) Medical School, Singapore, Singapore., Zhou Y; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Translational Stem Cell Biology Branch, National Institutes of Health, Bethesda, MD, United States.; Wellcome Medical Research Council (MRC) Trust Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Sealey M; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Arora S; Department of Mathematics, University of Oxford, Oxford, United Kingdom., Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Claridge TDW; Department of Chemistry, University of Oxford, Oxford, United Kingdom., Hillenbrand R; Biomarker Development, Novartis Pharma AG, Basel, Switzerland., Oechtering J; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Kuhle J; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Leppert D; Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Anthony DC; Department of Pharmacology, University of Oxford, Oxford, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Feb 04; Vol. 12, pp. 811351. Date of Electronic Publication: 2022 Feb 04 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2021.811351 |
